Literature DB >> 36044431

Retraction: Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19.

.   

Abstract

Entities:  

Year:  2022        PMID: 36044431      PMCID: PMC9432686          DOI: 10.1371/journal.pone.0273489

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


× No keyword cloud information.
The PLOS ONE Editors retract this article [1] because it was identified as one of a series of submissions for which we have concerns about authorship, competing interests, and peer review. We regret that the issues were not addressed prior to the article’s publication. ABG and MAA did not agree with the retraction. JL and ME responded but expressed neither agreement nor disagreement with the editorial decision. RMA and SMA either did not respond directly or could not be reached.
  1 in total

1.  Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19.

Authors:  Arun Bahadur Gurung; Mohammad Ajmal Ali; Joongku Lee; Mohamed El-Zaidy; Reem M Aljowaie; Saeedah M Almutairi
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.